https://www.selleckchem.com/pr....oducts/jnk-inhibitor
Growth arrest and DNA-damage-inducible 45 beta ( ) is overexpressed and is associated with poor clinical outcomes in many human cancers, but the clinical implication of in epithelial ovarian cancer (EOC) remains unclear. Bioinformatics analysis of The Cancer Genome Atlas (TCGA) and gene expression omnibus (GEO) cohorts was used to illustrate the relationship between expression and metastasis, as well as the survival time of EOC. was downregulated by siRNAs in EOC cells, and migration ability was determined by a transwell assa
Aimer
Commentaire
Partagez
